Literature DB >> 27186947

Detection of Human Papillomavirus Genotypes and Major BRCA Mutations in Familial Breast Cancer.

Parinaz Mohtasebi1, Hossein Rassi2, Fatemeh Maleki2, Sameh Hajimohammadi1, Zahra Bagheri2, Malihe Fakhar Miandoab1, Mahdieh Naserbakht1.   

Abstract

Breast cancer is a multistep disease and infection with a DNA virus could play a role in one or more of the steps in this pathogenic process. High-risk human papillomaviruses (HPVs) are the causative agents of several cancers. In this study, we investigated HPV genotypes associated with breast cancer and its relationship with BRCA mutation for the detection of familial breast cancer. We analyzed 84 formalin-fixed, paraffin-embedded tissue blocks from 38 familial breast cancer and 46 nonfamilial breast cancer samples by multiplex polymerase chain reaction and clinical parameters. Overall prevalence of HPV infection was 27 of 84: 10 (37.03%) HPV-16, 9 (29.62%) HPV-18, 4 (14.81%) HPV-11, 1 (3.7%) HPV-31, 1 (3.7%) HPV-33, and 2 (7.4%) HPV35. Furthermore, 17 mtDNA4977 deletions and 5 5382insC mutations were detected from 38 familial breast cancer samples. Our results demonstrate that infection with HPV was prevalent among Iranian women with familial breast cancer and the testing of mtDNA4977 deletions and 5382insC mutations in combination with clinical parameters as major risk factors can serve in the identification of familial breast cancer.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27186947     DOI: 10.1089/mab.2015.0081

Source DB:  PubMed          Journal:  Monoclon Antib Immunodiagn Immunother        ISSN: 2167-9436


  1 in total

1.  Presence of Human Papillomavirus DNA in Malignant Neoplasia and Non-Malignant Breast Disease.

Authors:  Erika Maldonado-Rodríguez; Marisa Hernández-Barrales; Adrián Reyes-López; Susana Godina-González; Perla I Gallegos-Flores; Edgar L Esparza-Ibarra; Irma E González-Curiel; Jesús Aguayo-Rojas; Adrián López-Saucedo; Gretel Mendoza-Almanza; Jorge L Ayala-Luján
Journal:  Curr Issues Mol Biol       Date:  2022-08-13       Impact factor: 2.976

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.